“Increasingly, bioconvergent therapeutics and hybrid products and services promise cures; with current pharmaco-economic pricing rationales, these will be cost-effective but they will
bankrupt the system.”
“At Catenion, I can put my scientific background in cell therapy and regenerative medicine to practical use and help bring innovative therapies to the market.”
“We develop strategies that empower our clients to drive innovation and bring new treatments from promises to patients.”
“Catenion provides an exciting workplace where science meets business. We aim to help our clients to reach patients sooner and better.”
“Change-Management is a team effort – let’s get started.”
“Translating new technologies into viable business ideas”
“Is biopharma ready to embrace the new biology?”
“Helping clients around the globe to unleash the power of immune system in the fight against a plethora of diseases is a very rewarding career path for a trained immunologist.”
“Ottobock HealthCare is the world market leader in prosthetics. Our major growth driver is the development and marketing of new and innovative products. With the intention to optimize our pipeline management we decided to implement portfolio management in our Prosthetics Business Unit. This has established great transparency regarding risk, commercial potential and strategic fit of R&D projects and marketed products. On that basis we are able to truly measure where we stand in R&D and in commercial terms versus our ambitious goals and are able to make timely adjustments, where required. Simultaneously portfolio management also supports our strategic planning of the development pipeline. During this entire journey, Catenion proved to be a true partner on strategic and operative levels for us and our teams.”
